Veeda Michelle Mediavillo Anlacan

Prof. Dr. Veeda Michelle Mediavillo Anlacan

Department of Neurosciences, College of Medicine, University of the Philippines Manila, Manila, Philippines
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
AEAdrian Espiritu
Adrian Espiritu
MSMarie Charmaine C. Sy
Marie Charmaine C. Sy
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora
Our study aimed to determine the effects of new-onset neurological symptoms (NNS) on clinically relevant outcomes in hospitalized patients with COVID-19 infection. We conducted a nationwide, comparative, retrospective, cohort study among adult, hospitalized COVID-19 patients involving 37 hospital sites from various regions in the Philippines. We included a total of 10,881 patients with confirmed COVID-19 infection (2008 had NNS while 8873 did not have NNS). The adjusted hazard ratios (aHRs) for mortality among the mild and severe cases were significantly higher by 1.660 (95% CI 1.132–2.435) and by 1.352 (95% CI 1.042–1.752), respectively, in the NNS group compared to those in the non-NNS group. The aHRs for respiratory failure in the NNS group were significantly increased by 1.914 (95% CI 1.346–2.722), by 1.614 (95% CI 1.260–2.068), and by 1.234 (95% CI 1.089–1.398) among the mild, severe, and critical cases, respectively. The aHRs for ICU admission in the NNS group were still significantly higher by 1.973 (95% CI 1.457–2.673) and by 1.831 (95% CI 1.506–2.226) among the mild and severe cases, respectively. Patients who had NNS were not significantly associated with a longer duration of ventilator dependence (adjusted odds ratio (aOR) 0.954, 95% CI 0.772–1.179), longer ICU stay (aOR 0.983, 95% CI 0.772–1.252) and longer hospital admission (aOR 1.045, 95% CI 0.947–1.153). The presence of NNS significantly increases the risk of mortality, respiratory failure and ICU admission among COVID-19 patients. Registration and associated protocol publication: ClinicalTrials.gov website (NCT04386083); Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. The Philippine COVID-19 Outcomes: a Retrospective study Of Neurological manifestations and Associated symptoms (The Philippine CORONA study): a protocol study. BMJ Open. 2020;10:e040944.

30 November 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
AEAdrian Espiritu
Adrian Espiritu
MSMarie Charmaine C Sy
Marie Charmaine C Sy
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora
Introduction: The SARS-CoV-2, virus that caused the COVID-19 global pandemic, possesses a neuroinvasive potential. Patients with COVID-19 infection present with neurological signs and symptoms aside from the usual respiratory affectation. Moreover, COVID-19 is associated with several neurological diseases and complications, which may eventually affect clinical outcomes.Objectives: The Philippine COVID-19 Outcomes: a Retrospective study Of Neurological manifestations and Associated symptoms (The Philippine CORONA) study investigators will conduct a nationwide, multicentre study involving 37 institutions that aims to determine the neurological manifestations and factors associated with clinical outcomes in COVID-19 infection.Methodology and analysis: This is a retrospective cohort study (comparative between patients with and without neurological manifestations) via medical chart review involving adult patients with COVID-19 infection. Sample size was determined at 1342 patients. Demographic, clinical and neurological profiles will be obtained and summarised using descriptive statistics. Student’s t-test for two independent samples and χ2 test will be used to determine differences between distributions. HRs and 95% CI will be used as an outcome measure. Kaplan-Meier curves will be constructed to plot the time to onset of mortality (survival), respiratory failure, intensive care unit (ICU) admission, duration of ventilator dependence, length of ICU stay and length of hospital stay. The log-rank test will be employed to compare the Kaplan-Meier curves. Stratified analysis will be performed to identify confounders and effects modifiers. To compute for adjusted HR with 95% CI, crude HR of outcomes will be adjusted according to the prespecified possible confounders. Cox proportional regression models will be used to determine significant factors of outcomes. Testing for goodness of fit will also be done using Hosmer-Lemeshow test. Subgroup analysis will be performed for proven prespecified effect modifiers. The effects of missing data and outliers will also be evaluated in this study.Ethics and dissemination: This protocol was approved by the Single Joint Research Ethics Board of the Philippine Department of Health (SJREB-2020–24) and the institutional review board of the different study sites. The dissemination of results will be conducted through scientific/medical conferences and through journal publication. The lay versions of the results may be provided on request.Trial registration number: NCT04386083.

27 December 2021 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
BPBernadeth Lyn C. Piamonte
Bernadeth Lyn C. Piamonte
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora
AEAdrian Espiritu
Adrian Espiritu
Introduction: Understanding the emergent role of the internet on the health-seeking behavior of people is critical not only in the areas of medicine and public health but also in the field of infodemiology. Methods: Using Google Trends, data on global search queries for Alzheimer disease (AD) between January 2004 and April 2021 were analyzed. The relationship between online interest, as reflected by search volume index (SVI), and measures of disease burden, namely prevalence, deaths, and disability-adjusted life years, was evaluated. Results: There was a reduction in the tendency to search for AD during the past two decades. SVI peaks corresponded to news of famous people with AD and awareness months. Symptoms, causes, and differences with the term dementia were central queries for persons interested in AD. No notable overall correlation between SVI and measures of disease burden was found due to competing results. Sub-group analyses, however, showed that these correlations may be influenced by socioeconomic development, with strong negative significant associations observed in lower middle-income countries. Conclusion: Online interest in AD may represent a more complex metric influenced by socioeconomic factors. Awareness of the impact of celebrity diagnosis and awareness months on online search behavior may prove useful in the planning of public health campaigns for AD.

16 September 2024 in The Lancet Regional Health - Western Pacific
Verified
Journal Article
Open access
COClaire O'CAllaghan
Claire O'CAllaghan
JMJohannes C. Michaelian
Johannes C. Michaelian
YAYoko Aihara
Yoko Aihara
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
CCChristopher Chen
Christopher Chen
SNSharon L. Naismith
Sharon L. Naismith
Here we first review the limited available literature addressing the current landscape of specialist assessment services for dementia and cognitive decline and the preparedness for new amyloid-targeting therapies for Alzheimer's disease across the Western Pacific region. Considering the scarcity of literature, as national representatives of Western Pacific nations we were then guided by the World Health Organization's Global Action Plan on Dementia to provide country-specific reviews. As a whole, we highlight that the existing diverse socioeconomic and cultural landscape across the region poses unique challenges, including varying access to services and marked differences among countries in their preparedness for upcoming amyloid-targeting therapies for Alzheimer's disease. Therefore, there is an urgent call for intergovernmental collaboration and investment across the Western Pacific to ensure that for all nations, citizens living with dementia and cognitive decline have access to effective and equitable methods of diagnosis, treatment and care.

25 January 2024 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
Veeda Michelle Mediavillo AnlacanVeeda Michelle Mediavillo Anlacan
Veeda Michelle Mediavillo Anlacan
PLPamela Danielle T. Lanuza
Pamela Danielle T. Lanuza
ASAnna Anjelica R. Sanchez
Anna Anjelica R. Sanchez
RJRoland Dominic G. Jamora
Roland Dominic G. Jamora
Background: Dementia prevalence is increasing in low- and middle-income countries such as the Philippines. Objective: This study aimed to give an overview of dementia care in the Philippines and to identify gaps in terms of local epidemiology, research, financial coverage, diagnostics, pharmacotherapy, manpower, and caregiver support. Methods: This scoping review was conducted using the Preferred Reporting Items for Systematic reviews and Meta-analysis guidelines extension for scoping reviews. Six international and two local databases, and government and non-government websites were searched. Data published in the English or Filipino language on dementia epidemiology, research, diagnostics, management, manpower, and training were extracted from the earliest indexed record until June 2022. Results: The prevalence of dementia in the Philippines is high and research output on all aspects of dementia is low. Cost is a major barrier as health care coverage is limited, with reliance mainly on out-of-pocket payments, leading to challenges in the proper diagnosis and treatment of dementia. There is a low specialist-to-population ratio, with shortages beyond manpower and training. Conclusions: Gaps in dementia care include limited published local data, high healthcare costs, inadequate health financing, and limited manpower.

31 March 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
AEAdrian Espiritu
Adrian Espiritu
NRNikolai Gil D. Reyes
Nikolai Gil D. Reyes
CLCarl Froilan D. Leochico
Carl Froilan D. Leochico
MSMarie Charmaine C. Sy
Marie Charmaine C. Sy
EVEmilio III Quilatan Villanueva
Emilio III Quilatan Villanueva
Roland Dominic G. JamoraRoland Dominic G. Jamora
Roland Dominic G. Jamora